世界の高血圧薬市場:業界調査2019年

QYResearchが発行した調査報告書(DATA910T06616)
◆英語タイトル:Global Hypertension Drug Market Professional Survey Report 2019
◆商品コード:DATA910T06616
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年12月6日
◆ページ数:109
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥378,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥567,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥756,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、高血圧薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カルシウムチャネル遮断薬、利尿薬、ベータ遮断薬血管拡張薬、アンジオテンシン変換酵素阻害薬、アルファ遮断薬、アンジオテンシン受容体遮断薬、レニン阻害薬に、用途別には、病院、私立医院、その他にセグメント区分し、高血圧薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・高血圧薬の世界市場概要
・高血圧薬の製造コスト構成分析
・高血圧薬の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・高血圧薬の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・高血圧薬のセグメント分析(種類別)
(カルシウムチャネル遮断薬、利尿薬、ベータ遮断薬血管拡張薬、アンジオテンシン変換酵素阻害薬、アルファ遮断薬、アンジオテンシン受容体遮断薬、レニン阻害薬)
・高血圧薬のセグメント分析(用途別)
(病院、私立医院、その他)
・高血圧薬の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Lupin Limited、Novartis AG、Daiichi - Sankyo、Pfizer Inc、Ranbaxy Laboratories Limited、Sanofi S.A、AstraZeneca Plc、Johnson & Johnson Ltd、Boehringer Ingelheim、Merck & Co.、)
・高血圧薬の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

Hypertension or high blood pressure is the condition when blood pressure increases to the unhealthy level. Hypertension is very harmful and it can lead to stroke, heart failure, heart attack and kidney diseases. The main purpose of anti-hypertension drug is to lower and control high blood pressure to protect organs like brain, heart, kidneys. Change in lifestyle and elevated stress levels have increased the prevalence of hypertension globally, thereby increasing the demand for hypertension drugs.

The global Hypertension Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Hypertension Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypertension Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hypertension Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hypertension Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Lupin Limited
Novartis AG
Daiichi – Sankyo
Pfizer Inc
Ranbaxy Laboratories Limited
Sanofi S.A
AstraZeneca Plc
Johnson & Johnson Ltd
Boehringer Ingelheim
Merck & Co.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Calcium Channel Blockers
Diuretics
Beta Blockers Vasodilators
Angiotensin Converting Enzyme Inhibitors
Alpha Blockers
Angiotensin Receptor Blockers
Renin Inhibitors

Segment by Application
Hospital
Private clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Hypertension Drug
1.1 Definition of Hypertension Drug
1.2 Hypertension Drug Segment by Type
1.2.1 Global Hypertension Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Calcium Channel Blockers
1.2.3 Diuretics
1.2.4 Beta Blockers Vasodilators
1.2.5 Angiotensin Converting Enzyme Inhibitors
1.2.6 Alpha Blockers
1.2.7 Angiotensin Receptor Blockers
1.2.8 Renin Inhibitors
1.3 Hypertension Drug Segment by Applications
1.3.1 Global Hypertension Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Private clinic
1.3.4 Others
1.4 Global Hypertension Drug Overall Market
1.4.1 Global Hypertension Drug Revenue (2014-2025)
1.4.2 Global Hypertension Drug Production (2014-2025)
1.4.3 North America Hypertension Drug Status and Prospect (2014-2025)
1.4.4 Europe Hypertension Drug Status and Prospect (2014-2025)
1.4.5 China Hypertension Drug Status and Prospect (2014-2025)
1.4.6 Japan Hypertension Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Hypertension Drug Status and Prospect (2014-2025)
1.4.8 India Hypertension Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hypertension Drug
2.3 Manufacturing Process Analysis of Hypertension Drug
2.4 Industry Chain Structure of Hypertension Drug

3 Development and Manufacturing Plants Analysis of Hypertension Drug
3.1 Capacity and Commercial Production Date
3.2 Global Hypertension Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Hypertension Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Hypertension Drug Production and Capacity Analysis
4.2 Hypertension Drug Revenue Analysis
4.3 Hypertension Drug Price Analysis
4.4 Market Concentration Degree

5 Hypertension Drug Regional Market Analysis
5.1 Hypertension Drug Production by Regions
5.1.1 Global Hypertension Drug Production by Regions
5.1.2 Global Hypertension Drug Revenue by Regions
5.2 Hypertension Drug Consumption by Regions
5.3 North America Hypertension Drug Market Analysis
5.3.1 North America Hypertension Drug Production
5.3.2 North America Hypertension Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Hypertension Drug Import and Export
5.4 Europe Hypertension Drug Market Analysis
5.4.1 Europe Hypertension Drug Production
5.4.2 Europe Hypertension Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Hypertension Drug Import and Export
5.5 China Hypertension Drug Market Analysis
5.5.1 China Hypertension Drug Production
5.5.2 China Hypertension Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Hypertension Drug Import and Export
5.6 Japan Hypertension Drug Market Analysis
5.6.1 Japan Hypertension Drug Production
5.6.2 Japan Hypertension Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Hypertension Drug Import and Export
5.7 Southeast Asia Hypertension Drug Market Analysis
5.7.1 Southeast Asia Hypertension Drug Production
5.7.2 Southeast Asia Hypertension Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Hypertension Drug Import and Export
5.8 India Hypertension Drug Market Analysis
5.8.1 India Hypertension Drug Production
5.8.2 India Hypertension Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Hypertension Drug Import and Export

6 Hypertension Drug Segment Market Analysis (by Type)
6.1 Global Hypertension Drug Production by Type
6.2 Global Hypertension Drug Revenue by Type
6.3 Hypertension Drug Price by Type

7 Hypertension Drug Segment Market Analysis (by Application)
7.1 Global Hypertension Drug Consumption by Application
7.2 Global Hypertension Drug Consumption Market Share by Application (2014-2019)

8 Hypertension Drug Major Manufacturers Analysis
8.1 Lupin Limited
8.1.1 Lupin Limited Hypertension Drug Production Sites and Area Served
8.1.2 Lupin Limited Product Introduction, Application and Specification
8.1.3 Lupin Limited Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Novartis AG
8.2.1 Novartis AG Hypertension Drug Production Sites and Area Served
8.2.2 Novartis AG Product Introduction, Application and Specification
8.2.3 Novartis AG Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Daiichi – Sankyo
8.3.1 Daiichi – Sankyo Hypertension Drug Production Sites and Area Served
8.3.2 Daiichi – Sankyo Product Introduction, Application and Specification
8.3.3 Daiichi – Sankyo Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Pfizer Inc
8.4.1 Pfizer Inc Hypertension Drug Production Sites and Area Served
8.4.2 Pfizer Inc Product Introduction, Application and Specification
8.4.3 Pfizer Inc Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Ranbaxy Laboratories Limited
8.5.1 Ranbaxy Laboratories Limited Hypertension Drug Production Sites and Area Served
8.5.2 Ranbaxy Laboratories Limited Product Introduction, Application and Specification
8.5.3 Ranbaxy Laboratories Limited Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Sanofi S.A
8.6.1 Sanofi S.A Hypertension Drug Production Sites and Area Served
8.6.2 Sanofi S.A Product Introduction, Application and Specification
8.6.3 Sanofi S.A Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 AstraZeneca Plc
8.7.1 AstraZeneca Plc Hypertension Drug Production Sites and Area Served
8.7.2 AstraZeneca Plc Product Introduction, Application and Specification
8.7.3 AstraZeneca Plc Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Johnson & Johnson Ltd
8.8.1 Johnson & Johnson Ltd Hypertension Drug Production Sites and Area Served
8.8.2 Johnson & Johnson Ltd Product Introduction, Application and Specification
8.8.3 Johnson & Johnson Ltd Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Boehringer Ingelheim
8.9.1 Boehringer Ingelheim Hypertension Drug Production Sites and Area Served
8.9.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.9.3 Boehringer Ingelheim Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Merck & Co.
8.10.1 Merck & Co. Hypertension Drug Production Sites and Area Served
8.10.2 Merck & Co. Product Introduction, Application and Specification
8.10.3 Merck & Co. Hypertension Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Hypertension Drug Market
9.1 Global Hypertension Drug Market Trend Analysis
9.1.1 Global Hypertension Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Hypertension Drug Regional Market Trend
9.2.1 North America Hypertension Drug Forecast 2019-2025
9.2.2 Europe Hypertension Drug Forecast 2019-2025
9.2.3 China Hypertension Drug Forecast 2019-2025
9.2.4 Japan Hypertension Drug Forecast 2019-2025
9.2.5 Southeast Asia Hypertension Drug Forecast 2019-2025
9.2.6 India Hypertension Drug Forecast 2019-2025
9.3 Hypertension Drug Market Trend (Product Type)
9.4 Hypertension Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Hypertension Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Hypertension Drug
Table Global Hypertension Drug Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Hypertension Drug Production Market Share by Types in 2018
Figure Calcium Channel Blockers Product Picture
Figure Diuretics Product Picture
Figure Beta Blockers Vasodilators Product Picture
Figure Angiotensin Converting Enzyme Inhibitors Product Picture
Figure Alpha Blockers Product Picture
Figure Angiotensin Receptor Blockers Product Picture
Figure Renin Inhibitors Product Picture
Table Global Hypertension Drug Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Hypertension Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Private clinic
Figure Others
Figure Global Hypertension Drug Revenue (Million USD) (2014-2025)
Figure Global Hypertension Drug Production (K Units) (2014-2025)
Figure North America Hypertension Drug Market Size (Million USD) (2014-2025)
Figure Europe Hypertension Drug Market Size (Million USD) (2014-2025)
Figure China Hypertension Drug Market Size (Million USD) (2014-2025)
Figure Japan Hypertension Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Hypertension Drug Market Size (Million USD) (2014-2025)
Figure India Hypertension Drug Market Size (Million USD) (2014-2025)
Table Hypertension Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hypertension Drug in 2018
Figure Manufacturing Process Analysis of Hypertension Drug
Figure Industry Chain Structure of Hypertension Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Hypertension Drug Manufacturing Plants Distribution
Table Hypertension Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Hypertension Drug Capacity (K Units) of Major Manufacturers (2014-2019)
Table Hypertension Drug Production (K Units) of Major Manufacturers (2014-2019)
Table Hypertension Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Hypertension Drug Production Share by Manufacturers in 2018
Table Hypertension Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Hypertension Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Hypertension Drug Revenue Share by Manufacturers in 2018
Table Hypertension Drug Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Hypertension Drug Production by Regions 2014-2019 (K Units)
Table Global Hypertension Drug Production Market Share by Regions 2014-2019
Figure Global Hypertension Drug Production Market Share by Regions in 2018
Table Global Hypertension Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Hypertension Drug Revenue Market Share by Regions 2014-2019
Figure Global Hypertension Drug Revenue Market Share by Regions in 2018
Table Global Hypertension Drug Consumption by Regions 2014-2019 (K Units)
Table Global Hypertension Drug Consumption Market Share by Regions 2014-2019
Figure North America Hypertension Drug Production Growth Rate 2014-2019 (K Units)
Figure North America Hypertension Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Hypertension Drug Production, Consumption Import and Export (K Units)
Figure Europe Hypertension Drug Production Growth Rate 2014-2019 (K Units)
Figure Europe Hypertension Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Hypertension Drug Production, Consumption Import and Export (K Units)
Figure China Hypertension Drug Production Growth Rate 2014-2019 (K Units)
Figure China Hypertension Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Hypertension Drug Production, Consumption Import and Export (K Units)
Figure Japan Hypertension Drug Production Growth Rate 2014-2019 (K Units)
Figure Japan Hypertension Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Hypertension Drug Production, Consumption Import and Export (K Units)
Figure Southeast Asia Hypertension Drug Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Hypertension Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Hypertension Drug Production, Consumption Import and Export (K Units)
Figure India Hypertension Drug Production Growth Rate 2014-2019 (K Units)
Figure India Hypertension Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Hypertension Drug Production, Consumption Import and Export (K Units)
Figure Global Consumption Hypertension Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Hypertension Drug Market Share by Application (2014-2019)
Table Lupin Limited Hypertension Drug Production Sites and Area Served
Table Lupin Limited Hypertension Drug Product Introduction, Application and Specification
Table Lupin Limited Hypertension Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Lupin Limited Hypertension Drug Production Growth Rate (2014-2019)
Table Lupin Limited Hypertension Drug Production Market Share (2014-2019)
Figure Lupin Limited Hypertension Drug Revenue Market Share (2014-2019)
Table Lupin Limited Hypertension Drug Main Business and Markets Served
Table Novartis AG Hypertension Drug Production Sites and Area Served
Table Novartis AG Hypertension Drug Product Introduction, Application and Specification
Table Novartis AG Hypertension Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG Hypertension Drug Production Growth Rate (2014-2019)
Table Novartis AG Hypertension Drug Production Market Share (2014-2019)
Figure Novartis AG Hypertension Drug Revenue Market Share (2014-2019)
Table Novartis AG Hypertension Drug Main Business and Markets Served
Table Daiichi - Sankyo Hypertension Drug Production Sites and Area Served
Table Daiichi - Sankyo Hypertension Drug Product Introduction, Application and Specification
Table Daiichi - Sankyo Hypertension Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Daiichi - Sankyo Hypertension Drug Production Growth Rate (2014-2019)
Table Daiichi - Sankyo Hypertension Drug Production Market Share (2014-2019)
Figure Daiichi - Sankyo Hypertension Drug Revenue Market Share (2014-2019)
Table Daiichi - Sankyo Hypertension Drug Main Business and Markets Served
Table Pfizer Inc Hypertension Drug Production Sites and Area Served
Table Pfizer Inc Hypertension Drug Product Introduction, Application and Specification
Table Pfizer Inc Hypertension Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Inc Hypertension Drug Production Growth Rate (2014-2019)
Table Pfizer Inc Hypertension Drug Production Market Share (2014-2019)
Figure Pfizer Inc Hypertension Drug Revenue Market Share (2014-2019)
Table Pfizer Inc Hypertension Drug Main Business and Markets Served
Table Ranbaxy Laboratories Limited Hypertension Drug Production Sites and Area Served
Table Ranbaxy Laboratories Limited Hypertension Drug Product Introduction, Application and Specification
Table Ranbaxy Laboratories Limited Hypertension Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Ranbaxy Laboratories Limited Hypertension Drug Production Growth Rate (2014-2019)
Table Ranbaxy Laboratories Limited Hypertension Drug Production Market Share (2014-2019)
Figure Ranbaxy Laboratories Limited Hypertension Drug Revenue Market Share (2014-2019)
Table Ranbaxy Laboratories Limited Hypertension Drug Main Business and Markets Served
Table Sanofi S.A Hypertension Drug Production Sites and Area Served
Table Sanofi S.A Hypertension Drug Product Introduction, Application and Specification
Table Sanofi S.A Hypertension Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi S.A Hypertension Drug Production Growth Rate (2014-2019)
Table Sanofi S.A Hypertension Drug Production Market Share (2014-2019)
Figure Sanofi S.A Hypertension Drug Revenue Market Share (2014-2019)
Table Sanofi S.A Hypertension Drug Main Business and Markets Served
Table AstraZeneca Plc Hypertension Drug Production Sites and Area Served
Table AstraZeneca Plc Hypertension Drug Product Introduction, Application and Specification
Table AstraZeneca Plc Hypertension Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Plc Hypertension Drug Production Growth Rate (2014-2019)
Table AstraZeneca Plc Hypertension Drug Production Market Share (2014-2019)
Figure AstraZeneca Plc Hypertension Drug Revenue Market Share (2014-2019)
Table AstraZeneca Plc Hypertension Drug Main Business and Markets Served
Table Johnson & Johnson Ltd Hypertension Drug Production Sites and Area Served
Table Johnson & Johnson Ltd Hypertension Drug Product Introduction, Application and Specification
Table Johnson & Johnson Ltd Hypertension Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Ltd Hypertension Drug Production Growth Rate (2014-2019)
Table Johnson & Johnson Ltd Hypertension Drug Production Market Share (2014-2019)
Figure Johnson & Johnson Ltd Hypertension Drug Revenue Market Share (2014-2019)
Table Johnson & Johnson Ltd Hypertension Drug Main Business and Markets Served
Table Boehringer Ingelheim Hypertension Drug Production Sites and Area Served
Table Boehringer Ingelheim Hypertension Drug Product Introduction, Application and Specification
Table Boehringer Ingelheim Hypertension Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Hypertension Drug Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Hypertension Drug Production Market Share (2014-2019)
Figure Boehringer Ingelheim Hypertension Drug Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Hypertension Drug Main Business and Markets Served
Table Merck & Co. Hypertension Drug Production Sites and Area Served
Table Merck & Co. Hypertension Drug Product Introduction, Application and Specification
Table Merck & Co. Hypertension Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co. Hypertension Drug Production Growth Rate (2014-2019)
Table Merck & Co. Hypertension Drug Production Market Share (2014-2019)
Figure Merck & Co. Hypertension Drug Revenue Market Share (2014-2019)
Table Merck & Co. Hypertension Drug Main Business and Markets Served
Figure Global Hypertension Drug Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Hypertension Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Hypertension Drug Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Hypertension Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Hypertension Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Hypertension Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Hypertension Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Hypertension Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Hypertension Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Hypertension Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Hypertension Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Hypertension Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Hypertension Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Hypertension Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Hypertension Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Hypertension Drug by Type (2019-2025)
Table Global Consumption (K Units) of Hypertension Drug by Application (2019-2025)
Table Hypertension Drug Distributors List
Table Hypertension Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Lupin Limited、Novartis AG、Daiichi - Sankyo、Pfizer Inc、Ranbaxy Laboratories Limited、Sanofi S.A、AstraZeneca Plc、Johnson & Johnson Ltd、Boehringer Ingelheim、Merck & Co.、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の高血圧薬市場:業界調査2019年(Global Hypertension Drug Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。